Literature DB >> 9526732

Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro.

Y C Chang1, K W Tai, M H Cheng, L S Chou, M Y Chou.   

Abstract

Betel quid chewing has been linked to oral submucous fibrosis and oral cancer. Cytotoxicity and genotoxicity assays were used to investigate the pathobiological effects of arecoline on cultured human buccal fibroblasts. Arecoline increased double-stranded polynucleic acid at the concentration of 0.1 to 10 micrograms/ml in a concentration-dependent manner. At a concentration higher than 50 micrograms/ml, arecoline was cytotoxic to cultured fibroblasts and the cytotoxicity was dose-dependent. No genotoxicity for arecoline was found even at a concentration of 400 micrograms/ml. On the other hand, 600 micrograms/ml glutathione (GSH) and 200 micrograms/ml glycyrrhizin could prevent the arecoline-induced cytotoxicity. These results indicate that arecoline is a cytotoxic agent and no genotoxicity was found to human buccal fibroblasts. Furthermore, increasing consumption of GSH- and glycyrrhizin-rich foods may reduce the oral diseases associated with betel quid chewing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9526732     DOI: 10.1111/j.1600-0714.1998.tb02096.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  10 in total

Review 1.  Management of oral submucous fibrosis: an overview.

Authors:  Punnya V Angadi; Sanjay Rao
Journal:  Oral Maxillofac Surg       Date:  2010-09

2.  Benefit of using muscle relaxants in the routine treatment protocol of oral submucosal fibrosis: a pilot study.

Authors:  Sunil Srichand Nichlani; Mohan V Jagade; Arunprabhu Ganeshan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-09-09

3.  Therapeutic interventions in oral submucous fibrosis: an experimental and clinical study.

Authors:  Vibha Singh; Shadab Mohammad; A P Pant; C S Saimbi; Ritesh Srivastava
Journal:  J Maxillofac Oral Surg       Date:  2014-10-07

Review 4.  Genetic toxicology and toxicokinetics of arecoline and related areca nut compounds: an updated review.

Authors:  Nuno G Oliveira; Daniela L Ramos; Ricardo Jorge Dinis-Oliveira
Journal:  Arch Toxicol       Date:  2020-10-24       Impact factor: 5.153

5.  Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.

Authors:  Shiuan-Shinn Lee; Yi-Juai Chen; Chung-Hung Tsai; Fu-Mei Huang; Yu-Chao Chang
Journal:  Clin Oral Investig       Date:  2015-09-04       Impact factor: 3.573

6.  Study of oral potentially malignant disorders related to various risk factors amongst the patients attending hospitals in Bhopal, India.

Authors:  Swati Balsaraf; Ajay Bhambal; Revant Chole
Journal:  Med Pharm Rep       Date:  2019-01-15

7.  Egr-1 mediates low-dose arecoline induced human oral mucosa fibroblast proliferation via transactivation of Wnt5a expression.

Authors:  Qiang Chen; Jiuyang Jiao; Youyuan Wang; Zhihui Mai; Jing Ren; Sijie He; Xiaolan Li; Zheng Chen
Journal:  BMC Mol Cell Biol       Date:  2020-11-10

8.  Fat mass and obesity-associated protein regulates tumorigenesis of arecoline-promoted human oral carcinoma.

Authors:  Xia Li; Xiaoli Xie; Yangcong Gu; Jianming Zhang; Jiang Song; Xiufeng Cheng; Yijun Gao; Yilong Ai
Journal:  Cancer Med       Date:  2021-08-11       Impact factor: 4.452

9.  The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan.

Authors:  C-H Lee; Y-C Ko; H-L Huang; Y-Y Chao; C-C Tsai; T-Y Shieh; L-M Lin
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

10.  Elevated snail expression mediates tumor progression in areca quid chewing-associated oral squamous cell carcinoma via reactive oxygen species.

Authors:  Shiuan-Shinn Lee; Chung-Hung Tsai; Cheng-Chia Yu; Yu-Chao Chang
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.